Navigation Links
Diabetes researcher gets $5M boost
Date:10/21/2008

A respected Queensland University of Technology researcher and his team have received $5 million from the Juvenile Diabetes Foundation International, the third-biggest grant they have ever given to an Australian research team.

Professor Nathan Efron of QUT's Institute of Health and Biomedical Innovation is the principal researcher of the five year study, which will test the efficacy of detecting the progress of diabetic neuropathy by looking at the nerves in the cornea, at the front of the eye.

Diabetic neuropathy is a condition affecting around 50 per cent of diabetic patients at varying degrees of severity, which causes the degeneration of nerves, mostly in the arms and leg.

Professor Efron has found that the nerves affected by neuropathy are an exact match to nerves found in front of the eye, and this study will test whether looking at their level of degeneration in these nerves over a period of time would match the nerve degeneration found in arms and legs.

"We want to see how well the degeneration of the nerves in the cornea matches the degeneration of nerves throughout the body, and if it matches it will mean that we can monitor diabetic neuropathy using a simple eye test," Professor Efron said.

"Over the next five years, we have 400 patients with diabetes who we will be testing on two sites - here at QUT and at the University of Manchester in England - who will receive this test, called corneal confocal microscopy, to see the value in tracking the condition in this way."

Diabetic neuropathy is currently measured by taking a skin biopsy from the foot, and running tests which could take up to three days, whereas the quick and non-invasive eye tests would see results in a matter of minutes.

Professor Efron said there were multiple benefits of being able to measure the onset of neuropathy, one being that there were drugs in development which aim to cure diabetic neuropathy.

"When thes
'/>"/>

Contact: Sharon Thompson
sharon.thompson@qut.edu.au
073-138-4494
Queensland University of Technology
Source:Eurekalert

Page: 1 2

Related biology news :

1. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
2. Gender, coupled with diabetes, affects vascular disease development
3. Breakthrough research identifies how cells from pigs may cure diabetes
4. Botched production of insulin molecule may lead to diabetes
5. Joslin researchers uncover potential role of leptin in diabetes
6. Insulins brain impact links drugs and diabetes
7. Exercise improves thinking, reduces diabetes risk in overweight children
8. UVa Health System team uncovers genes role in type 1 diabetes
9. Childrens Hospital studying drug with the potential to prevent/delay onset of type 1 diabetes
10. JDRF awards University of Copenhagen professor with grant to conduct innovative diabetes research
11. Cancer and arthritis therapy may be promising treatment for diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... Ohio State University cancer researchers have de...rain-tumor cells and blocks the growth of new tumo...uses designed to kill cancer cells oncolytic viru...ain tumors if they also carry a gene for a protein..., called vasculostatin, is normally produced in th...
(Date:12/1/2009)...W YORK, Dec. 1 iQor, a global prov...s, was included in the 2009 InfoWorld 100 Awards...led ERP system, TeQ21. This was the first submissi...d among this prestigious list of companies," said ... completely transforming the way we do business, a...
(Date:12/1/2009)...ke a bad cold, can spread among groups of people, ...ity of California-San Diego and Harvard shows., ...hat has been following health conditions for more ...y people tend to share their loneliness with other...ected people moves to the fringes of social networ...
Breaking Biology News(10 mins):Tumor-attacking virus strikes with 'one-two punch' 2iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2Loneliness can be contagious 2Loneliness can be contagious 3Putney Inc Enters the 24175M Annual Veterinary NSAID Market 49830 1Putney Inc Enters the 24175M Annual Veterinary NSAID Market 49830 2CorNova 28R 29 Receives CE Mark Approval for Valecor Platinum 28R 29 Coronary Stent System 49827 1CorNova 28R 29 Receives CE Mark Approval for Valecor Platinum 28R 29 Coronary Stent System 49827 2Cinergy Health Commentary On President Obamas Call for Cost Control Competition in Health Insurance Arena 49824 1Cinergy Health Commentary On President Obamas Call for Cost Control Competition in Health Insurance Arena 49824 2
... New Brunswick, N.J. The National Science Founda...ent of Homeland Security (DHS), has awarded Rutger...ing smuggled nuclear materials. The work aims to t...lop dirty bombs or environmental contaminants that... paralyze commerce. , The NSF has committed $631,...
... By mining evidence from the classic films made b...that the left-handed minority suffered something o... of the 20th century. In more recent times, leftie...ort in the Sept. 18, 2007, Current Biology, a publ...portant because more than 10 percent of people hav...
... Washington DC*-- Key components of a new approac...hed into space Friday as part of a twelve-day, low...ity in the space radiation environmenta prelude fu...d on technology similar to that used in pregnancy ... in the Life Marker Chip (LMC) experiment, which h...
Other Biology News:Homeland Security awards 2 grants to Rutgers for nuclear threat detection 2Homeland Security awards 2 grants to Rutgers for nuclear threat detection 3Films of Mitchell and Kenyon illuminate lefties' decline in Victorian England 2Life on Mars 'pregnancy test' successfully launched 2
(Date:12/2/2009)...., Dec. 2 According to the Nationa... Americans diagnosed with diabetes already have so...pathy, damage to the retina caused by leaky blood ...ith diabetes and is one of the most feared diabeti... patients who,ve had diabetes for 10 years or more...
(Date:12/1/2009)...K, Dec. 1 Reportlinker.com announc...in its catalogue: ,, Emerging Clinical Trial L... changing healthcare and regulatory environment ,...g-Clinical-Trial-Locations---Eastern-Europe-Market...ry-environment.html ,, Over the last decade ph...
(Date:12/1/2009)...la., Dec. 1 Expanding its European...Inc. of Sarasota has appointed Lake Chemicals and ...is located near Birmingham, England. ,, Osprey...ve the agricultural, waste water, and environmenta...to open drain fields, and clean up industrial and ...
(Date:12/1/2009)... Congruent Software agrees to migrate their Micros...ing clients) to Synergy Business Solutions to main...eattle, WA (PRWEB) December 1, 2009 -- Synergy Bus...e Microsoft Dynamics SL practice of Congruent Soft... The move was necessary due to a change in Congrue...
Breaking Biology Technology:Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 2Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 3
... The American Institute of Aeronautics and Astrona...ulsion Science , that compiles for the first time ...epts as space drives, warp drives, gravity control...would revolutionize spaceflight and enable human v...t matter may sound like science fiction, authors M...
...y 3 deCODE genetics,(Nasdaq: DCGN ) announced th...the Nasdaq Listing Qualifications Panel (the "Pane...ng of deCODE,s common stock from the Nasdaq Global... the open of the trading,session on Wednesday, Feb...,one of the three market tier designations for Nas...
...sty, Inc. (Amex: UPI ),a medical device company ...,proprietary products to treat voiding dysfunction...quarter of fiscal 2009 ended December 31, 2008. N... $3.4 million versus $3.7,million during last fisc... conjunction with the release of our fiscal second...
Other Biology Technology:New book from AIAA explores space drives, warp drives 2deCODE Announces Transfer of the Listing of its Common Stock from Nasdaq Global Market to Nasdaq Capital Market 2deCODE Announces Transfer of the Listing of its Common Stock from Nasdaq Global Market to Nasdaq Capital Market 3Uroplasty Reports Third Quarter Fiscal 2009 Results 2Uroplasty Reports Third Quarter Fiscal 2009 Results 3Uroplasty Reports Third Quarter Fiscal 2009 Results 4Uroplasty Reports Third Quarter Fiscal 2009 Results 5Uroplasty Reports Third Quarter Fiscal 2009 Results 6Uroplasty Reports Third Quarter Fiscal 2009 Results 7Uroplasty Reports Third Quarter Fiscal 2009 Results 8Uroplasty Reports Third Quarter Fiscal 2009 Results 9Uroplasty Reports Third Quarter Fiscal 2009 Results 10Uroplasty Reports Third Quarter Fiscal 2009 Results 11
Mouse Anti-Kusabira Orange Monoclonal Antibody, Unconjugated, Clone 2G9 from MBL International
Goat Anti-SPFH2 Polyclonal Antibody, Unconjugated from Abcam
Goat Anti-Als2 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Kusabira Orange Monoclonal Antibody, Unconjugated, Clone 2G9 from MBL International
Biology Products: